Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Sanofi | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: Sanofi

Revenues up 3% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi

4Q Revenues: €8.9 billion (+3%)

4Q Earnings: €811 million (+130%)

FY Revenues: €33.8 billion (-1%)

FY Earnings: €4.8 billion (+9%)

Comments: Sanofi Genzyme (Specialty Care) sales were €1.3 billion in the quarter, up 13% driven by multiple sclerosis products. Sanofi Pasteur GBU revenue grew 4% to €1.4 billion due to strong pediatric combination franchise sales. Diabetes and Cardiovascular GBU sales were €1.7 billion up 4%, with diabetes franchise sales up 2%. Rare Disease sales increased 10% to €716 million driven by the accrual of patients worldwide and strong performance of the franchise in Emerging Markets. Oncology sales were down 4% to €369 million. Consumer Healthcare sales increased 3% to €834 million driven by the performance in Europe. Generics sales were flat at €468 million. Results in the quarter include discontinued operations of the Animal Health business.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters